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Abstract
αβ T cell receptors recognize multiple antigenic peptides bound and presented by major
histocompatibility complex molecules. TCR cross-reactivity has been attributed in part to
flexibility of the complementarity-determining region loops, yet there have been limited direct
studies of loop dynamics to determine the extent of its role. Here we studied the flexibility of the
binding loops of the αβ TCR A6 utilizing crystallographic, spectroscopic, and computational
methods. A significant role for flexibility in binding and cross-reactivity was indicated only for the
CDR3α and CDR3β hypervariable loops. Examination of the energy landscapes of these two loops
indicated that CDR3β possesses a broad, smooth landscape, leading to the rapid sampling in the
free TCR of a range of conformations compatible with different ligands. The landscape for
CDR3α is more rugged, resulting in limited conformational sampling that leads to specificity
towards a reduced set of peptides as well as MHC. In addition to informing on the mechanisms of
cross-reactivity and specificity, the energy landscapes of the two loops indicate a complex
mechanism for TCR binding, incorporating elements of both conformational selection and
induced-fit in a manner that blends features of popular models for TCR recognition.
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Introduction
Elimination of pathogens by the T cell arm of the immune system requires T cell recognition
of an antigenic peptide bound and presented by class I or class II major histocompatibility
complex (MHC) proteins. Recognition occurs via the T cell receptor (TCR), a clonotypic,
heterodimeric cell-surface receptor. A defining characteristic of TCRs is their capacity to
recognize multiple peptide/MHC ligands, necessary due to the fixed size of the T cell
repertoire relative to the larger array of potential peptide antigens 1. In addition to ensuring
© 2011 Elsevier Ltd. All rights reserved.
*Corresponding author: brian-baker@nd.edu, Phone: (574) 631-9810, Fax: (574) 631-6652.
2Current address: is QuantumBio, Inc., State College, PA
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our
customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of
the resulting proof before it is published in its final citable form. Please note that during the production process errors may be
discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.




J Mol Biol. Author manuscript; available in PMC 2012 December 2.
Published in final edited form as:













reactivity against antigens derived from pathogens, TCR cross-reactivity is also necessary in
the development and maintenance of the T cell repertoire and is believed to underlie several
autoimmune pathologies and the rejection of transplanted tissues. Yet TCRs are not highly
degenerate, showing specificity towards particular peptide subsets and, via the phenomenon
of MHC restriction, usually recognizing peptides presented by a subset of MHC alleles.
Flexibility of the TCR antigen binding site is frequently discussed as an underlying
contributor to cross-reactivity. Binding site flexibility has been inferred from
crystallographic structures of bound and free TCRs, which frequently show differences in
the conformation of complementarity determining region (CDR) loops (reviewed in ref. 2).
Flexibility has also been inferred from multiple structures of the same TCR bound to
different pMHC ligands, in which CDR loops often adopt different conformations (e.g., refs.
3; 4; 5). Significant attention has been paid to the hypervariable CDR3 loops, which usually
form the most interactions with the peptide in TCR-pMHC crystal structures 6. Moreover,
when bound and free TCRs are compared, the CDR3 loops show the largest overall changes
in conformation 2.
Conformational changes upon binding such as those seen for TCR CDR3 loops are often
attributed to induced-fit type motions occurring after initial contact. Induced-fit is embodied
in the two-step mechanism for TCR cross-reactivity, which proposes that the TCR adjusts to
the peptide after initial contact to MHC 7. An alternative (but not mutually exclusive)
mechanism for conformational changes upon binding is the “selection” of a compatible
conformation from a pre-existing structural equilibrium 8; 9. For TCRs, conformational
selection is embodied in the “conformer” model, which proposes that distinct conformations
of a TCR generated via a pre-existing equilibrium maintain specificity for different
ligands 10.
Both conformational selection and induced-fit as general mechanisms for protein binding
and selectivity have received considerable attention in recent years 8; 9; 11. Both reflect the
underlying structural and energetic landscapes of the interacting molecules, with the actual
binding mechanism dependent on the “roughness” of these landscapes, i.e., the energies of
various conformational substates and the height of the barriers between them. Yet while
both induced-fit and conformational selection have been postulated to play roles in TCR
binding and cross-reactivity, there have been few studies evaluating the intrinsic flexibilities
of TCR binding loops. An NMR study of the D10 TCR reported greater flexibility of the
CDR3α and CDR3β loops in the picosecond time scale 12. Stopped-flow kinetic
measurements have shown that the interaction of a cytomegalovirus peptide-specific TCR
with its ligand is rate-limited by an induced-fit mechanism, but the location and magnitude
of the associated structural changes that occur during binding is unknown 13.
Thermodynamic studies have suggested that a number of TCRs must undergo
conformational changes during binding (reviewed in ref. 14), but these are also unable to
address specific changes and cannot discriminate between binding mechanisms. The
resulting uncertainty about the intrinsic flexibility of CDR3 loops has led to
characterizations ranging from unstructured loops that require folding upon binding 7 to
ordered loops that undergo remodeling or rigid body shifts upon binding 15. That different
CDR3 loop sequences will invariably possess different degrees of flexibility adds a further
complication.
The αβ TCR A6 is among the most well characterized T cell receptors, with crystallographic
structures available for the TCR bound to nine ligands. These include the Tax peptide
(LLFGYPVYV) 16, the HuD peptide (LGYGFVNYI) 17, the Tel1p peptide
(MLWGYLQYV) 18, and six single amino acid variants of the Tax peptide 19; 20; 21, all
presented by the class I MHC HLA-A*0201 (HLA-A2). These structures comprise the
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largest structural database available for a single TCR. A distinctive feature of this database
is the variability in the conformation of the CDR3β loop, which adjusts significantly in
response to different ligands. In contrast, the positions of CDR3α and the remaining loops
are independent of the peptide. This structural database together with available physical and
biological data regarding A6 binding, specificity, and cross-reactivity provides a unique
opportunity to study the structural and energetic landscapes of a TCR’s CDR loops and
establish their roles in binding and cross-reactivity.
We began by determining the structure of the free A6 TCR, which revealed that both the
CDR3α and CDR3β hypervariable loops must undergo conformational adjustments in order
to bind. However, in the free TCR the CDR3α and CDR3β loops possess different degrees
of flexibility, as shown by time-resolved fluorescence measurements. Together with
molecular dynamics simulations and additional structural and thermodynamic data, our
results indicate that CDR3β possesses a relatively smooth, broad energy landscape, allowing
the free TCR to rapidly sample a range of conformations compatible with ligands that
possess structural and chemical heterogeneity across the center of the peptide. The landscape
of CDR3α is more rugged, leading to slower and more restrained motion that restricts the
receptor to a more defined set of peptides, and likely only those presented by HLA-A2.
Altogether, the data indicate that cross-reactivity and specificity are pre-programmed into
the energy landscapes of the A6 TCR’s hypervariable loops, with the TCR interacting via a
mechanism that blends elements of both conformational selection as well as induced-fit, thus
reflecting aspects of both the conformer and two-step model for TCR recognition.
Results
Structure of the free A6 T cell receptor indicates structural heterogeneity for CDR3α and
CDR3β
We first determined the structure of the free A6 TCR to 2.2 Å resolution. The protein
crystallized in space group P21 with two molecules per asymmetric unit (Table 1). Both
molecules adopted the characteristic TCR immunoglobulin fold. The two molecules in the
asymmetric unit were nearly identical, with the backbones of the variable domains
superimposing with an RMS deviation of only 0.9 Å (Fig. 1A). The conformations of the
germline-encoded CDR1 and CDR2 loops of the α and β chains were identical in both
copies of the molecule. Differences, however, were seen between the two copies of the
CDR3α and CDR3β loops. For CDR3α, the electron density in the second molecule in the
asymmetric unit was noticeably poorer than that for the first, with large intermittent gaps
along the loop backbone (Fig. 1B). Despite the weaker density, the chain was fully traced,
which together with the conformation in the first molecule in the asymmetric unit revealed
two conformations for CDR3α.
Electron density was even weaker for CDR3β, with gaps for the first molecule in the
asymmetric unit and missing density for the central Ala99-Gly100-Gly101-Arg102 sequence
in the second molecule (Fig.1C). The structure thus indicates that both CDR3α and CDR3β
possess static disorder within the crystal, with greater amounts of disorder for CDR3β than
CDR3α. There were no crystallographic contacts to the backbones of the CDR3α/CDR3β
loops in either molecule in the asymmetric unit.
Comparison of free and bound A6 reveals structural adaptations that occur upon binding
are concentrated in CDR3α and CDR3β
To compare the structure of the free and bound TCR, we superimposed the variable domains
from each A6-peptide/HLA-A2 complex whose structure has been solved onto those of the
free receptor. For free A6, we utilized the coordinates for the first molecule in the
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asymmetric unit, for which the electron density for both CDR3 loops was clearer and for
which both chains could be fully traced. Figure 2A shows the free and bound conformations
of the CDR3α and CDR3β loops relative to the peptide and MHC positions. The structural
diversity in CDR3β is apparent, as is the conserved positioning of CDR3α. The
conformations of the two loops in the free TCR, however, differ from those adopted when
bound.
For CDR3α, the most significant difference between free and bound is in the backbone φ/ψ
angles of Gly102, which between free and bound differ by an average of 151° and 116° for
φ and ψ, respectively. The large backbone rotations at Gly102 together with smaller
rotations (8° – 60°) for the remainder of the residues of CDR3α result in a shift of the free
loop relative to the conformation it adopts in the A6-peptide/HLA-A2 ternary complexes.
The result of the shift is a 90° twist at the loop’s apex. Not shown for simplicity in Fig. 2A is
the conformation of CDR3α seen in the second molecule in the asymmetric unit, for which
the electron density was poor. This conformation was closer to that seen in the bound state
(Fig. S1), with the apex of the loop twisted into its bound conformation and the rest of the
loop differing by ψ bond rotations at Trp101 and Lys103 near the C-terminal end of the
loop.
In all structures of A6 bound to ligand, CDR3α interacts directly with the peptide, contacting
the side chain at position 5 and hydrogen bonding to the glycine at peptide position 4. The
comparison between free and bound indicates that formation of these interactions is
facilitated by the need to avoid steric clashes with HLA-A2. As shown in Fig. 2B, multiple
clashes occur between CDR3α and HLA-A2 when the variable domains of the free TCR are
superimposed onto those of the bound. These clashes, involving Arg65, Lys66, and Ala69
on the HLA-A2 α1 helix, exist regardless of which A6-peptide/HLA-A2 complex is used for
the superimposition, as well as if free peptide/HLA-A2 structures are used instead (the
conformations of Arg65/Lys66/Ala69 do not change significantly upon TCR binding). Thus,
the conformation of CDR3α and the interactions it forms with peptides is directly influenced
by the MHC.
The comparison between free and bound is more complex for CDR3β, owing to the broader
distribution seen in the various A6-peptide/HLA-A2 complexes. The conformation of the
loop in the free structure differs from that in any of the complexes, consisting of a
displacement at the N-terminal end and a tighter turn near the loop apex. Depending on the
ligand recognized, significant angular changes between the free and bound loop
conformations were seen for Gly97, Leu98, Gly100, and Gly101 (Fig. S4).
Other than CDR3α and CDR3β, the only other difference in CDR loop positioning between
the free and various bound forms of A6 was seen for CDR1β, which differed by a small
rigid body translation, best summarized by a 1.4 Å shift of the α carbon of Glu30 (Fig. 2C).
Time-resolved fluorescence anisotropy reveals CDR3β moves faster than CDR3α on the
nanosecond timescale
To assess the backbone flexibility of the A6 CDR3α and CDR3β loops, we performed time-
resolved fluorescence anisotropy (TRFA) experiments on the two loops. Single cysteine
mutations were made within the two loops to allow for fluorescent labeling. Two separate
mutations were made in the CDR3α loop (S100C and W101C) and four separate mutations
within the CDR3β loop (A99C, G100C, G101C, and R102C). The positions span the apexes
of both loops, and for CDR3β, include the positions for which electron density is missing in
the second molecule in the asymmetric unit of the structure of the free TCR. As a positive
control, we also examined position 195 in HLA-A2, a previously-characterized highly
flexible site at the tip of the HLA-A2 α3 domain 18.
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For each labeled site, backbone flexibility was assessed via TRFA utilizing time-correlated
single-photon counting. With fluorescein-5-maleimide as a probe, in all cases, anisotropy
decayed more rapidly for CDR3β than for CDR3α, although not as fast as the positive
control (Fig. 3). These results indicate faster nanosecond dynamics for CDR3β and are
consistent with the differences in electron density seen in the structure of the free TCR. To
extract quantitative information, the data were fit to a biexponential decay function to
determine fast and slow correlation times and their associated amplitudes. In TRFA with
nanosecond-lifetime probes, the fast correlation time reports on local backbone motion
whereas the slow correlation time reports on overall protein tumbling 22; 23; 24.
As shown in Table 2, the fast correlation times (θf) were as much as two-fold faster for
CDR3β than for CDR3α. Moreover, the contributions of backbone flexibility to the overall
anisotropy decay (ff) were roughly two-fold greater for CDR3β than for CDR3α. The apex
of CDR3β thus moves faster and with greater amplitude than the apex of CDR3α, consistent
with the electron density seen for the free TCR. Both timescale and amplitude are reflected
in the ratios of ff to θf, which combine amplitude and time constants into a single empirical
parameter to facilitate comparisons of overall flexibility 23; 24. Notably, the ff/θf ratios are at
least two-fold higher for residues in CDR3β than CDR3α.
Some variation was seen in the slow correlation time θs, although the average of 14 ns is
close to the value expected for a 50 kDa globular protein 25. The variation in θs is not
unexpected given our use of fluorescein, whose fluorescence lifetime is three- to four-fold
smaller than the expected θs, resulting in little fluorescence signal to report on overall
protein tumbling in the presence of faster modes of anisotropy decay. For the same reason,
seemingly faster and less accurate values of θs are expected as backbone flexibility
increases 22, as is observed in the data.
The measurements at positions 101 in CDR3α and CDR3β were repeated using BODIPY-FL
malemide as a fluorescent probe (Fig. S2). BODIPY-FL has spectral characteristics very
similar to fluorescein, yet possesses different structural and chemical properties. The
correlation times and amplitudes obtained with BODIPY-FL differed somewhat when
compared to the those obtained with fluorescein, as expected given the differences in
structure, chemistry, and fluorescence lifetime between fluorescein and BODIPY-FL.
However, the overall conclusions from the BODIPY-FL data were the same: faster decay
was observed for CDR3β than for CDR3α. Importantly, the ratios of the ff/θf values between
the CDR3β and CDR3α data for position 101 were the same for the BODIPY-FL and
fluorescein data, verifying quantitatively the faster motion for CDR3β.
Molecular dynamics simulations indicate CDR3α moves slowly between bound and free
conformations whereas CDR3β rapidly samples a more extensive range of conformations
We next examined the flexibility of the free A6 TCR using molecular dynamics (MD)
simulations. We began by running five independent 40ns trajectories (200 ns of total
simulation time), beginning with the coordinates for the first molecule in the asymmetric
unit. Backbone flexibility was examined by calculating atomic displacement (in the form of
B-factors) for the α carbons of the TCR. Over the full 200 ns, the CDR3α and CDR3β loops
showed the highest degree of flexibility in the α and β variable domains (Fig. 4A). In
agreement with the crystallographic and TRFA data, CDR3β showed greater flexibility than
CDR3α, with an approximately 60% higher average displacement for the loop apex
compared to CDR3α. A covariance analysis between the residues of the two loops,
calculated over the full 200 ns of simulation time, indicated only marginal coupled motion
between the residues of CDR3α and CDR3β (Fig. S3).
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To more quantitatively examine the conformations adopted by CDR3α and CDR3β during
the MD simulations, we calculated RMS deviations of the CDR3α and CDR3β loops relative
to the starting conformation and the conformations adopted in the structures of A6 bound to
Tax/HLA-A2 16 and Tel1p/HLA-A2 18. For the majority of simulation time, the backbone of
CDR3α remained close to the starting conformation (average RMSD relative to start was 0.5
Å; average RMSD relative to the bound state with the Tax and Tel1p peptides was 1.5 Å)
(Fig. 4B). However, in the third 40-ns MD segment, CDR3α moved to and remained in a
conformation more similar to that seen in the bound states (average RMSD relative to the
bound state with the Tax peptide was 1.0 Å, with a minimum value of 0.3 Å).
In good agreement with the comparison of the free and bound TCR structures, the
movement between the free and bound-like conformations of CDR3α was controlled largely
by φ/ψ bond rotations at Gly102 and Thr93 (Fig. S4). Partial movement towards the bound
state was seen in the fourth MD segment, in which the Gly102 φ bond moved within 30° of
the value in the bound state, although the overall conformation of the loop remained closer
to that observed in the free rather than bound TCR.
The third molecular dynamics segment in which CDR3α switched to a bound-like
conformation was continued for an additional 60 ns, during which CDR3α remained in this
conformation. The observation of only a single conformational switch for CDR3α over 260
ns of simulation time implies a high energy barrier separating the loop’s free and bound
conformations.
Unlike CDR3α, CDR3β sampled multiple conformations during the simulations, mirroring
those seen in the various A6-peptide/HLA-A2 complexes. The loop did not remain in any
one state for an appreciable length of time (Fig. 4C). Notably, Leu98, Ala99, Gly100,
Gly101, and Arg102 of CDR3β sampled the φ/ψ dihedral angles present in all known A6-
peptide/HLA-A2 crystal structures (Fig. S5). The observation of multiple, more easily
accessible conformations indicates a broader and smoother energy landscape for CDR3β
compared to CDR3α.
Coordinates for CDR3α and CDR3β output every 4 ns are shown superimposed in Fig. 4D.
The free and bound-like conformations observed for CDR3α are highlighted, as is the range
of conformations observed for CDR3β. Superimposition of these conformations onto the
A6-Tax/HLA-A2 complex confirmed that the steric overlaps between CDR3α and HLA-A2
persisted while the loop remained in its free conformation.
Finally, we ran an additional 200 ns of simulation on the A6 TCR in its bound-state
conformation, beginning with the coordinates of A6 bound to Tax-P6A/HLA-A2, with the
pMHC removed 19. During this “reverse” simulation, despite the absence of the pMHC, the
backbone of CDR3α remained near its starting, bound conformation, supporting the
conclusion that the energy barrier separating the bound and free conformations for CDR3α
is high in both directions. CDR3β, on the other hand, sampled a range of conformations in
the reverse simulation, showing dynamic behavior nearly identical to that observed when the
simulation was begun with the coordinates for the free TCR (Fig. S6).
A6 recognition of the Tax-Y5F variant confirms CDR3β possesses a smooth energy
landscape
The data so far suggest a broad, smooth energy landscape for CDR3β, leading to the rapid
sampling of multiple conformations in the free TCR. To test whether these conformations
are compatible with different ligands, we determined the structure of the A6 TCR in
complex with HLA-A2 presenting a variant of the Tax peptide in which the central Tyr5
residue was replaced with phenylalanine (Tax-Y5F). We previously observed a correlation
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between the presence or absence of a hydrogen bond donor or acceptor at position 5 of the
Tax peptide and the conformation of CDR3β 17, and hypothesized that simply replacing
Tyr5 with phenylalanine would alter loop conformation. Importantly, Tax-Y5F is
recognized with affinities and kinetics identical within error to those for native Tax/HLA-
A2 26. An altered CDR3β conformation with Tax-Y5F would thus indicate that the smooth
energy landscape of CDR3β spans multiple binding-competent conformations.
The A6-Tax-Y5F/HLA-A2 complex crystallized in space group C2 with unit cell parameters
similar to those for A6 bound to the native Tax/HLA-A2 ligand (Table 1 and Fig. S7).
Overall, the two complexes were essentially the same (Fig. 5A), with all α carbons
superimposing with an RMSD of 0.8 Å. As hypothesized though, CDR3β was shifted into a
more open conformation (Fig. 5B), displacing its apex 3.3 Å towards the HLA-A2 α2 helix.
The change in CDR3β was identical to that seen upon A6 recognition of the HuD peptide 17,
and only slightly smaller than that seen upon recognition of a Tax variant with doubly-
fluorinated phenylalanine at position five 21. As with both of these ligands, the loss of a
hydrogen bond between the peptide and Arg95 of CDR3β was compensated by the
formation of a salt-bridge between Arg102 of CDR3β and Glu154 of the HLA-A2 heavy
chain (Fig. 5C–E). The loss of a single hydrogen bond is thus sufficient to trigger an altered
CDR3β conformation, in this case due to the need to optimize interface electrostatics.
When considered alongside the previously published binding data 26, the simplest
interpretation of the structural data with the Tax-Y5F peptide is that the change in loop
conformation between native Tax and Tax-Y5F costs little in free energy and that a
significant barrier does not separate the conformations. To confirm this, we compared the
thermodynamics of A6 recognition of native and Tax-Y5F using isothermal titration
calorimetry (ITC), reasoning that a more complex mechanism behind the shift in loop
conformation should result in a substantial change to the binding thermodynamics.
ITC experiments for A6 recognition of Tax/HLA-A2 and Tax-Y5F/HLA-A2 are shown in
Fig. 6. The thermodynamic parameters for recognition of the native Tax ligand are in
excellent agreement with those determined previously and show the unfavorable enthalpy
change and favorable entropy change that characterizes A6 recognition of ligand 27; 28.
Importantly, recognition of the Tax-Y5F ligand shows the same profile, with ΔG° values
identical within error. Recognition of Tax-Y5F is slightly more unfavorable enthalpically
and favorable entropically (ΔΔH° = 1.5 kcal/mol, ΔΔS° = 4 cal/mol/K), consistent with the
electrostatic alterations in the interface and the greater hydrophobicity of phenylalanine
compared to tyrosine. However, the conservation of the distinctive overall thermodynamic
profile supports the overall conclusion regarding CDR3β: the loop possesses a smooth
energy landscape that rapidly samples multiple conformations that are competent ligands
that vary structural and chemical features across the center of the peptide.
Discussion
The energy landscapes of CDR3α and CDR3β control A6 TCR cross-reactivity and
specificity
To gain insight into how T cell receptor flexibility impacts binding and cross-reactivity, we
examined the energy landscapes of the A6 TCR, focusing on the backbones of the
hypervariable CDR3α and CDR3β loops. The data indicate that both CDR3α and CDR3β
must adjust to recognize incoming ligands, consistent with kinetic data, which show that A6
binds the Tax/HLA-A2 ligand at rates below the diffusion limit when electrostatics are
screened 27. The need for conformational adjustments is also consistent with measurements
of binding thermodynamics, which again for recognition of Tax/HLA-A2, indicate that a
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large entropic penalty must be overcome after accounting for changes in solvation and other
binding-linked effects 28.
However, although both the CDR3α and CDR3β loops must adjust to ligand, their
underlying energy landscapes and resulting intrinsic flexibilities are different, as
diagrammed in Fig. 7. CDR3β possesses a broad, relatively smooth energy landscape (Fig.
7A), leading to the rapid sampling of multiple conformations compatible with a range of
ligands that alter size, shape, and electrostatic features across the center of the peptide. The
consequences of this behavior are highlighted when recognition of the Tax and Tax-Y5F
ligands is compared: despite requiring different conformations for CDR3β, the TCR binds
the two with the same affinity, kinetics, and distinctive thermodynamic profile. The
negligible impact on binding kinetics is particularly informative, as this indicates that not
only can the adoption of different CDR3β conformations cost little or nothing in free energy,
it can occur at rates fast relative to receptor-ligand association. The negligible impact on
association rate for a ligand requiring an altered A6 CDR3β conformation is not limited to
the Tax-Y5F peptide, as this has also been seen with fluorinated Tax variants 21. For at least
a subset of ligands then, CDR3β can participate in rapid conformational selection, with
various ligands “selecting” a compatible conformation from a rapidly fluctuating ensemble.
Unlike CDR3β, the energy landscape for CDR3α is characterized by two more restricted
conformational wells, separated by a high barrier that is gated by hinge rotations at the
beginning and end of the loop (Fig. 7B). The conformations sampled in one of these wells
are binding-incompetent, as evidenced by the overlaps between elements of the loop and
HLA-A2 when the free and bound A6 structures are superimposed. The conformations
sampled in the second well closely resemble the conformation adopted in the various A6-
peptide/HLA-A2 crystal structures. The ability of CDR3α to sample a binding-competent
state in the free TCR indicates that CDR3α may also participate in conformational selection,
with ligand binding to the fraction of TCRs which in which CDR3α is binding-competent
resulting in a redistribution of the conformational equilibrium in the free TCR. However, the
high barrier in the CDR3α landscape and the resulting slower movement compared to
CDR3β could also promote an induced-fit style interaction for the fraction of receptors for
which CDR3α is incompetent, as shown in Fig. 7C. Although the probability of an induced-
fit occurrence for CDR3α would be impacted by the presence of steric overlaps between
CDR3α and HLA-A2, these could be forcibly avoided if binding is driven via interactions
elsewhere in the interface (e.g., through interactions with the germline-encoded CDR1 or
CDR2 loops and/or a binding-competent CDR3β conformation). High concentrations can
also shift binding trajectories towards induced-fit pathways 11; 29, an effect which
physiologically will be magnified for TCRs and their ligands due to membrane tethering.
Irrespective of the mechanisms by which it engages, the conformation adopted by CDR3α in
the bound state of the A6 TCR does not vary with different peptides. While it is possible that
a different conformation could be seen in a new crystallographic structure, the energy
landscape of CDR3α indicates that adoption of another conformation will be slow and
thermodynamically expensive. In contrast with CDR3β, CDR3α thus appears to limit A6
cross-reactivity to a reduced set of ligands compatible with this single CDR3α conformation.
For peptides, this may translate into those with a glycine at peptide position 4. A glycine at
position 4 is the only conserved amino acid at the peptide center in all known A6 ligands 30,
and a hydrogen bond from Ser100α to the carbonyl of Gly4 is the only CDR3α-peptide
interaction conserved in all 10 A6-peptide/HLA-A2 crystal structures. Not unexpectedly, A6
tolerates substitutions to Gly4 very poorly.
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The conformational properties of CDR3α influence A6 TCR restriction towards HLA-A2
In addition to peptide specificity, the use of a single CDR3α conformation in the bound
states of A6 also appears to contribute to specificity (i.e., restriction) towards HLA-A2. In
all 10 A6-peptide/HLAA2 ternary complexes, CDR3α interacts with Arg65, Lys66, and
Ala69 of the HLA-A2 α1 helix. Mutations at each of these sites substantially weakens A6
binding 31; 32; 33. The side chains of Arg65, Lys66, and Ala69 all clash with the binding-
incompetent state of CDR3α, indicating that the contributions of these side chains to binding
results not only from the formation of intermolecular interactions, but also the need to avoid
what would otherwise be unfavorable steric clashes.
Interestingly, Arg65, Lys66, and Ala69 are all polymorphic sites in class I MHC molecules.
The clashes with Arg65 are of particular interest, as they include backbone and β carbon
atoms of the TCR and thus cannot all be resolved with side chain rotamer changes in the
TCR. These clashes would be eliminated by replacement of Arg65 with shorter amino acids,
such as the glutamine or asparagine present in most HLA-B alleles. Removal of these
clashes would provide less energetic “incentive” for the loop to adopt a conformation
compatible with HLA-A2. Thus, restriction of the A6 TCR towards HLA-A2 appears to be
governed in part by how the conformational ensemble of CDR3α interfaces with HLA-A2.
Seemingly unproductive CDR loop flexibility may be a product of thymic selection
The energy landscape of CDR3α may at first glance be puzzling: as the CDR3α
conformation is invariant in different ternary structures, why does the loop sample a
binding-incompetent conformation at all, i.e., why is it not rigid and locked into a binding-
competent form? One answer could be that the degree of CDR3α flexibility is simply a
consequence of the amino acid sequence needed to ensure the loop can adopt a conformation
compatible with peptide and HLA-A2. However, as with any TCR that has passed positive
selection, A6 recognizes a number of self-antigens weakly 30. If A6 possessed a more rigid
CDR3α loop, these self-antigens would be recognized with stronger affinities, possibly
leading to deletion of A6-expressing T cell clones during negative selection. Thymic
education may thus select for differing degrees flexibility not only to influence TCR cross-
reactivity and MHC restriction, but as a strategy to tune receptor binding affinities.
The binding mechanism of A6 blends elements of both the conformer and two-step TCR
binding models
The observation that both CDR3α and CDR3β sample conformations resembling their
bound states in the free TCR is consistent with the conformer model for TCR cross-
reactivity 10, which incorporates the general principles of conformational selection as
traditionally envisioned. As discussed above however, it remains possible that CDR3α could
also engage via an induced-fit mechanism, reflecting some aspects of the two-step TCR
binding model 7. This “blending” of elements of two popular models for TCR recognition
reflects the reality that conformational selection and induced-fit are extremes on a
continuum 8, with actual binding mechanisms a complex function of multiple variables,
including association kinetics, energies of binding intermediates, and the potentially
disparate energy landscapes of interacting regions.
Furthermore, our emphasis here has been on the backbones of the hypervariable loops.
Optimizations will be needed in some side chain positions, even for the germline-encoded
loops whose backbones are pre-configured to bind. As has been seen for other proteins 34,
some of these optimizations may proceed via an induced-fit mechanism, regardless of
whether conformational selection occurs earlier during binding. Our discussion has also
ignored the energy landscapes of peptide and MHC, which possess their own
complexities 18. Nonetheless, it is clear that for the A6 TCR, specificity and cross-reactivity
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are essentially pre-programmed into the energy landscapes and the resulting conformational
ensembles of the two CDR3 loops.
To what extent can the principles identified here be applied to other T cell receptors or TCR
recognition in general? As noted above, TCR CDR3α and CDR3β loops show the greatest
differences between free and bound receptors, and frequently adopt different conformations
in the structures of a single TCR bound to multiple ligands 2. The murine 2C TCR, for
which structures are also available with several ligands, shows considerable diversity in
CDR3α as well as conserved positioning in CDR3β and the germline-encoded loops 3; 35; 36.
While the 2C structures together with the NMR data available for the D10 TCR 12 suggests
a theme regarding the intrinsic variability of TCR hypervariable vs. germline loops (if not
CDR3α vs. CDR3β), similar dynamics measurements are not available for 2C. Further, it
may be notable that among crystallographic structures of free TCRs, only four out of 13
have sufficiently weak electron density prohibiting the conformation of a hypervariable loop
to be fully modeled (in addition to A6, the others are 2B4, ELS4, and 1.D9.B2) 37; 38; 39.
While it thus seems reasonable to conclude that the hypervariable CDR loops will generally
possess the greatest extent of intrinsic flexibility as seen here, additional data are needed to
uncover the extent to which general trends exist in how such flexibility is utilized. In the
interim, the data with A6 provide an instructional example against which the recognition
mechanisms of other TCRs can be compared.
Lastly, the observation of disparate degrees of flexibility within a protein binding site and
the consequences for cross-reactivity, specificity, and binding mechanism is instructive for
protein-protein interactions in general. Of particular interest are other proteins with large
numbers of binding partners, e.g., the “hubs” in protein interaction networks 40. Although
conformational variability is one mechanism considered to underlie general binding
promiscuity, the results here suggest a more nuanced consideration may be helpful. For
example, taking cues from the limited variability of the A6 CDR3α loop, slow switching
between discrete but relatively stable conformations in one region of a binding site could
bias recognition between different classes of targets. Rapid fluctuations within a broad
conformational ensemble elsewhere in the interface, as seen with A6 CDR3β, could then
fine tune the recognition towards different targets within a class. As implied by the work
with the A6 TCR, this view requires detailed studies not only of the rate limiting motions of
a recognition protein, but the underlying energy landscapes of multiple regions.
Materials & Methods
Proteins and peptides
Soluble A6 and HLA-A2 were purified from refolded E. coli-expressed inclusion bodies as
previously described 27. The TCR utilized an engineered disulfide bond across the constant
domains for improved stability 41. Cysteine mutations were introduced via Quickchange
mutagenesis (Stratagene). The S195C mutant of the HLA-A2 heavy chain was previously
generated 21. The Tax and Tax-Y5F peptide were synthesized locally with an ABI 433A
instrument or purchased commercially (Genscript). Peptides were chromatographically
purified and validated via mass spectrometry.
X-ray crystallography
Crystals of the free A6 TCR were grown from 30% PEG 4000, 0.1 M TRIS, pH 8.5.
Crystals of A6- Tax-Y5F/HLA-A2 were grown from 15% PEG 4000 in 0.1 M Tris, pH 8.5,
0.2 M MgCl2. Cryo-protection for all crystals consisted of 20–25% glycerol. Diffraction
data were collected at Argonne National Laboratory at the indicated beamlines at 100 K.
Data reduction, structure solution, refinement, and structure validation was performed as
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previously described 20, except that Phaser 42 was used to solve the free A6 structure and
MolProbitiy 43 was utilized as an additional evaluation tool during and after refinement.
Coordinates for the search model for the free A6 structure were from PDB entry 1QRN 19
with the pMHC and CDR loops removed. Coordinates for the search model for the Tax-Y5F
complex were from PDB entry 2GJ6 20 with the peptide and CDR loops removed.
Time-resolved fluorescence anisotropy
Refolded and purified A6 or Tax/HLA-A2 single cysteine mutants in 20 mM phosphate, 75
mM NaCl, pH 7.0 at concentrations from 25 to 40 µM were labeled with a ten-fold molar
excess of fluorescein-5-maleimide or BODIPY-FL maleimide (Invitrogen) together with 10
– 20 µM TCEP to prevent formation of disulfide-linked dimers. The final volumes of the
labeling reactions were 0.5–1.0 mL. After mixing for 45 minutes at room temperature,
excess label was removed by dialysis followed by size exclusion chromatography. Parallel
labeling reactions with wild-type protein containing no free cysteine were used to evaluate
non-specific labeling. Labeling efficiencies ranged from 11–80% as determined by A280/
A495 ratios. Non-specific labeling never exceeded 2%. UV images of reduced/non-reduced
SDS-PAGE gels verified that fluorescence emanated only from the chain with the cysteine
mutant. Fluorescence intensity measurements collected with a Beacon 2000 instrument
(Invitrogen) confirmed that wild-type protein had insignificant amounts of non-covalently
associated label.
Time-correlated single-photon counting (TCSPC) fluorescence lifetimes and anisotropies of
labeled A6 TCR mutants were measured at 25 °C using a HORIBA Jobin Yvon 5000U
FluoroCube (fluorescein samples) or a FluoroLog 3 (BODIPY-FL samples)
spectrofluorometer. Samples were excited with a 457-nm or 460-nm NanoLED pulsed
diodes at a repetition rate of 1 MHz, and time-correlated single-photon-counting by TBX-04
or TBX-05 detectors was collected at an emission wavelength of 515 nm. Anisotropy
measurements were collected as the emission polarizer was toggled between parallel and
perpendicular positions relative to the vertically oriented excitation polarizer until a
minimum peak difference of 10,000 counts was reached. The G-factor was experimentally
determined to adjust for polarization bias. Data were analyzed by the sum/difference
impulse reconvolution approach 22; 23; 24, in which a fit of the decay of the emission
intensity free of anisotropy effects is used to constrain a fit of the intensity decay including
anisotropy effects. The data were best fit by a biexponential function to account for
depolarization with two time constants:
where r is the anisotropy at time t, θf and θs are fast and slow correlation times and βf and βs
are the associated amplitudes. Independently collected lifetime measurements did not vary
from values calculated from the total emission decay. Fluorescence lifetimes did not vary
appreciably with labeling position. Reported values for the time constants and amplitudes
are the averages and standard deviations of a minimum of seven separate measurements.
Molecular dynamics simulations
MD simulations and analysis were performed using the AMBER 10 suite 44 utilizing the
ff99sb force field 45. The starting coordinates of the A6 TCR were taken from the first
molecule in the asymmetric unit of the free A6 structure, for which the electron density of
CDR3α and CDR3β was most complete (the “forward” simulation), or from the structure of
A6 bound to Tax-P6A/HLA-A2 19 leaving out the pMHC (the “reverse” simulation).
Molecules were neutralized with sodium ions and solvated using SPC/E waters. Molecules
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were energy minimized and heated to 300K using a Langevin thermostat 46. After
minimization, solute restraints were gradually relaxed from 25 to 0 kcal/mol/Å2 over 100 ps
of dynamics while keeping the pressure at 1 atm. The volume was then fixed and
temperature constraints removed to convert to a NVE ensemble. Equilibration consisted of 2
ns of dynamics. Production simulation consisted of 40 ns of dynamics, utilizing a 2 fs time
step and the SHAKE algorithm. Additional simulations were produced starting with the 5,
10, 15, and 20 ns coordinate files from the first 40 ns simulation. To ensure statistical
independence, each new simulation was re-equilibrated and run for an additional 40 ns (100
ns for the 15 ns, “third segment” branch). B-factors, RMSD plots, dihedral angles, and
superimpositions were calculated using the ptraj program of the AMBER suite.
Isothermal titration calorimetry
Titration calorimetry was performed with a Microcal VP-ITC (GE Healthcare). Titrations
were performed with TCR in the syringe and pMHC in the calorimeter cell. Starting
concentrations were 15 µM for pMHC and 150 µM for TCR. Solution conditions were 20
mM HEPES, 150 mM NaCl, pH 7.4, 4 °C. ITC injection volumes were 10 µL and injections
were performed over 12 s spaced 300 s apart to allow for a return to baseline. A separate
titration of TCR into buffer was performed to account for heats of dilution. Data were
processed and integrated with the software distributed with the instrument. Data were fit to a
single site binding model with the nonlinear fitting package using OriginPro 7.5
(OriginLabs). The first data point was excluded from analysis due to dilution across the
injection needle tip.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Structure of the unligated A6 TCR indicates conformational diversity in CDR3α and
CDR3β. A) Superimposition of the two molecules in the asymmetric unit of the free A6 unit
cell. B) 2Fo-Fc electron density contoured at 1σ for CDR3α in the first (left) and second
(right) molecules in the asymmetric unit. Density around the backbone for the first molecule
is nearly complete, whereas significant gaps were seen in the second. C) 2Fo-Fc electron
density contoured at 1σ for CDR3β in the first (left) and second (right) molecules in the
asymmetric unit. Density gaps around the backbone were seen for the first molecule,
whereas in the second molecule density was absent for the Ala-Gly-Gly-Arg sequence
beginning at residue 99.
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Conformational adjustments in both CDR3α and CDR3β are required for A6 recognition of
peptide/HLA-A2 ligands. A) Stereo image showing how the conformations of CDR3α and
CDR3β differ between bound and free, produced by superimposing the backbones of the
variable domains of all crystallized forms of A6. The coordinates of the first molecule in the
asymmetric unit were utilized for free A6. The peptide and HLA-A2 are shown to aid in
orientation. The color scheme is on the right. The positions of various residues of interest are
indicated. B) Steric clashes occur between atoms of CDR3α and HLA-A2 when free A6 is
superimposed onto bound, as indicated by the red dashed lines. These clashes remain if free
HLA-A2 is superimposed onto bound. C) Differences between free and bound are minimal
for loops other than CDR3α and CDR3β. The view is through HLA-A2 onto the binding site
of the TCR, with the peptide shown for clarity. The color scheme is the same as in panel A.
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Time-resolved fluorescence anisotropy indicates CDR3β moves more rapidly than CDR3α.
Anisotropy decay curves are shown on the left, while labeling positions are shown on the
right. In all cases, anisotropy decayed faster for CDR3β than for CDR3α. Neither loop
moved as rapidly as the disordered tip of the HLA-A2 α3 domain. Solid lines show fits to a
bi-exponential decay model. The LED prompt indicates the instrument pulse. Data for
BODIPY-FL-labeled samples is in Fig. S2.
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Molecular dynamics simulations support the dynamics measurements and place them in a
structural context. A) B-factors for the α carbons of the A6 Vα and Vβ domains indicate that
CDR3α and CDR3β are the most dynamic, with the apex of CDR3β showing approximately
60% greater displacement than that of CDR3α. B) RMSD from various configurations for
the residues of CDR3α (V92 – K103). For the majority of simulation time, CDR3α remained
in a set of conformations closely resembling its starting, unligated conformation. In the third
40 ns trajectory, CDR3α sampled a conformation more closely resembling that of the bound
state. C) RMSD from various configurations for the residues of CDR3β (S94 – E105).
Unlike CDR3α, CDR3β sampled a range of conformations, and did not remain in any single
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state for an appreciable length of time. D) 50 structural snapshots from the simulation,
averaged over subsequent 4ns blocks. The two general conformations adopted by CDR3α
are colored orange and grey. The orange conformations illustrate those closest to the bound
state of CDR3α, observed during the third 40ns segment. The wide range of conformations
adopted by CDR3β are also apparent.
Scott et al. Page 20














The structure of A6 bound to Tax-Y5F/HLA-A2 supports a broad, smooth energy landscape
for CDR3β. A) Superimposition of the structure of the complexes with native Tax and Tax-
Y5F highlight the overall structural similarities between the two complexes. The color
scheme is indicated in the inset. B) Close-up of the region around CDR3β, showing the shift
in CDR3β conformation in response to replacing Tyr5 of the Tax peptide with
phenylalanine. The shift is largest at the α carbon of Gly101, which moves 3.3 Å relative to
its position with native Tax. The color scheme is the same as in panel A. C) The
conformation of CDR3β in the Tax-Y5F structure is nearly identical to that seen in the
structure with the HuD peptide. D) The hydrogen bond made between Tyr5 and Arg95β in
the structure with native Tax. E) Loss of the Tyr5-CDR3β hydrogen bond is compensated by
the formation of a salt-bridge between Arg102 of CDR3β and HLA-A2 in the Tax-Y5F
structure, as also seen with the HuD peptide 17 and fluorinated Tax variants 21.
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Isothermal titration calorimetry indicates A6 recognition of Tax-Y5F/HLA-A2 proceeds
with an affinity identical within error and the same distinctive thermodynamic profile as
recognition of native Tax/HLA-A2. A–B) Calorimetric titration of Tax/HLA-A2 (A) and
Tax-Y5F/HLA-A2 (B) with the A6 TCR. Upper panels show the baseline corrected
titrations; lower panels show the fits to single site binding models and associated
thermodynamic parameters.
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Models of the energy landscapes of CDR3α and CDR3β. In all panels, free energy is on the
vertical axis and conformational space on the horizontal axis. A) The energy landscape of
CDR3β is broad and relatively smooth, facilitating rapid sampling of multiple binding-
competent conformations in the free TCR. B) The energy landscape of CDR3α is more
rugged than that of CDR3β, consisting of two more narrow wells separated by a higher
energy barrier. Movement over the barrier between the two wells is controlled by hinges on
either end of the CDR3α loop. Although the barrier is high in both directions, the relative
energies of the two wells are unknown, indicated by the use of dashed lines to describe each
well. Conformations sampled in one of the wells resemble that seen in the structure of the
unbound TCR, whereas conformations sampled in the other resemble that seen in the
structures of the bound TCR. The wells indicate some heterogeneity to account for
fluctuations around the two general conformations. C) Depending on the stability of the
TCR-pMHC intermediate, the landscape of CDR3α could lead to both conformational
selection and induced-fit. For an induced-fit pathway, the energy of the intermediate present
in the induced-fit pathway will be high, but will be reduced by increases in
concentration 11; 29 and local conformational rearrangements.
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Table 1
X-ray data collection and refinement statistics
Free A6 A6-Tax-Y5F/HLA-A2
Data collection
Source APS 19BM APS 21ID-F
Space group P21 C2
Cell dimensions
    a, b, c (Å) 91.2,51.7,96.3 224.0, 48.1, 93.0
    α, β, γ (°) 90.0, 105.05, 90.0 90.0, 91.0, 90.0
Resolution (Å) 20-2.19 (2.24-2.19)* 30-2.29 (2.34-2.29)
Unique reflections 44707 44526
Rmerge 0.070 (0.578) 0.066 (0.598)
I / σI 16.6 (2.0) 25.5 (2.7)
Completeness (%) 99.6 (99.1) 99.1 (98.5)
Redundancy 3.5 (3.5) 5.7 (5.8)
Refinement
Resolution (Å) 20-2.19 20-2.29
Reflections used 44693 44464
Rwork / Rfree (%) 0.21 / 0.27 0.22 / 0.27
No. atoms
    Protein 6864 6639
    Ligand/ion 70 66
    Water 256 193
Average B-factors (Å2)
    TCR 44 49
    Peptide 47
    MHC 49
    Ligand/ion 53 50
    Water 39 52
RMS deviations
    Bond lengths (Å) 0.019 0.012
    Bond angles (°) 1.87 1.55
Ramachandran statistics (%)
    Most favored 93.5 89.1
    Allowed 5.3 10.4
    Generously allowed 1.2 0.5
PDB entry 3QH3 3QFJ
*
Values in parentheses are for highest-resolution shell.
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Table 2
Correlation times and amplitudes from the time-resolved fluorescence anisotropy data.a
Position θf (ns) b θs (ns) c ff (×100%) d ff/θfe
CDR3α
S100 1.13 ± 0.51 18.3 ± 1.0 19.2 ± 4.5 0.23 ± 0.15
W101 0.89 ± 0.34 17.5 ± 1.5 26.3 ± 3.2 0.35 ± 0.17
W101 (BDPY)f 1.40 ± 0.08 13.6 ± 0.3 37.3 ± 1.2 0.27 ± 0.01
CDR3β
A99 0.55 ± 0.12 16.9 ± 1.0 41.7 ± 2.4 0.80 ± 0.21
G100 0.79 ± 0.26 15.0 ± 1.2 39.4 ± 2.4 0.56 ± 0.20
G101 0.80 ± 0.19 11.0 ± 1.1 52.3 ± 1.9 0.68 ± 0.15
G101 (BDPY)f 1.12 ± 0.02 14.6 ± 0.3 54.5 ± 0.1 0.49 ± 0.01
R102 0.67 ± 0.12 11.8 ± 0.4 38.6 ± 2.1 0.60 ± 0.13
HLA-A2
S195 0.45 ± 0.03 8.3 ± 0.6 74.1 ± 0.9 1.68 ± 0.12
a
From the quantitative analysis of the TRFA decay curves. Values represent the averages and standard deviations of a minimum of seven
independent measurements.
b
Fast correlation time, reflecting backbone motion
c
Slow correlation time, reflecting overall protein tumbling
d
Amplitude of fast decay phase, reflecting percent contribution of backbone motion to overall anisotropy decay
e
Amplitude of fast decay normalized by fast correlation time, reflecting the contributions of both amplitude and correlation time to overall
anisotropy decay. Higher numbers translate into greater/faster dynamics
f
Collected using BODIPY-FL as a fluorescent probe. All other measurements utilized fluorescein.
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